Inmune Bio, Inc. (INMB) — Net Income

Annual figures by fiscal year, from SEC filings.

2017: -$831.5K2018: -$12.44M2019: -$7.68M2020: -$12.10M2021: -$30.34M2022: -$27.30M2023: -$30.01M2024: -$42.08M2025: -$45.93M-$45.93M
2017Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$45.93M-9.2%
2024-$42.08M-40.2%
2023-$30.01M-9.9%
2022-$27.30M+10.0%
2021-$30.34M-150.8%
2020-$12.10M-57.6%
2019-$7.68M+38.3%
2018-$12.44M-1396.1%
2017-$831.5K